Sponsor pipeline

China National Biotec Group Company Limited clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 1		1
Phase 3		1

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT05091619	A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components)…	Whooping Cough	Active, Not Recruiting	2025-09-15
Phase 1
NCT07377175	Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After…	Smallpox	Recruiting	2026-01-29
Not specified
NCT07338851	the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines	Polio	Not Yet Recruiting	2026-01-14

Get alerts when China National Biotec Group Company Limited's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.